Expression of the stress response oncoprotein LEDGF/p75 in human cancer: A study of 21 tumor types

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Basu, Anamika ^a   Rojas, Heather ^a   Banerjee, Hiya ^b   Cabrera, Irena B ^a   Perez, Kayla Y ^a   de León, Marino ^a   Casiano, Carlos A ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LENS EPITHELIUM DERIVED GROWTH FACTOR; MESSENGER RNA; PROTEIN P75; LENS EPITHELIUM-DERIVED GROWTH FACTOR; SIGNAL PEPTIDE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER STAGING; CANCER TISSUE; COLON CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GENETIC DATABASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MICROARRAY ANALYSIS; POLYMERASE CHAIN REACTION; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; THYROID CANCER; TISSUE MICROARRAY; UPREGULATION; UTERUS CANCER; ANIMAL; DNA MICROARRAY; GENETICS; METABOLISM; NEOPLASM; RAT; RNA INTERFERENCE; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; RATS; RNA INTERFERENCE;

EID: 84856014798     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030132     Document Type: Article

References (50)

1. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB, (2010) Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 49: 1603-1616.
2. Pani G, Galeotti T, Chiarugi P, (2010) Metastasis: cancer cell's escape from oxidative stress. Cancer Metastasis Rev 29: 351-378.
3. Mena S, Ortega A, Estrela JM, (2009) Oxidative stress in environmental-induced carcinogenesis. Mutat Res 674: 36-44.
4. Singh DP, Ohguro N, Kikuchi T, Sueno T, Reddy VN, et al. (2000) Lens epithelium-derived growth factor: effects on growth and survival of lens epithelial cells, keratinocytes, and fibroblasts. Biochem Biophys Res Commun 267: 373-381.
5. Sharma P, Singh DP, Fatma N, Chylack LT Jr, Shinohara T, (2000) Activation of LEDGF gene by thermal-and oxidative-stresses. Biochem Biophys Res Commun 276: 1320-1324.
6. Matsui H, Lin LR, Singh DP, Shinohara T, Reddy VN, (2002) Lens epithelium-derived growth factor: increased survival and decreased DNA breakage of human RPE cells induced by oxidative stress. Invest Ophthalmol Vis Sci 42: 2935-2941.
7. Wu X, Daniels T, Molinaro C, Lilly MB, Casiano CA, (2002) Caspase cleavage of the nuclear autoantigen LEDGF/p75 abrogates its pro-survival function: implications for autoimmunity in atopic disorders. Cell Death Differ 9: 915-925.
8. Ge H, Si Y, Roeder RG, (1998) Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation. EMBO J 17: 6723-6729.
9. Sutherland HG, Newton K, Brownstein DG, Holmes MC, Kress C, et al. (2006) Disruption of Ledgf/Psip1 results in perinatal mortality and homeotic skeletal transformations. Mol Cell Biol 26: 7201-7210.
10. Ochs RL, Muro Y, Si Y, Ge H, Chan EK, et al. (2000) Autoantibodies to DFS 70 kd/transcription coactivator p75 in atopic dermatitis and other conditions. J Allergy Clin Immunol 105: 1211-1220.
11. Ganapathy V, Casiano CA, (2004) Autoimmunity to the nuclear autoantigen DFS70 (LEDGF): what exactly are the autoantibodies trying to tell us? Arthritis Rheum 50: 684-688.
12. Leoh LS, Mediavilla-Varela M, Basu A, Casiano CA, (2009) Autoantibodies to LEDGFp75/DFS70: natural autoantibodies or sensors of an augmented state of cellular oxidative stress? In: Conrad K, Chan EKL, Fritzler MJ, Humbel RL, von Landenberg P, Shoenfeld Y, editors. Pathogenesis to Therapy of Autoimmune Diseases. Autoimmunity, Autoantigens, and Autoantibodies PABST Science Publishers: Lengerich, Germany pp. 135-156.
13. Van Maele B, Busschots K, Vandekerckhove L, Christ F, Debyser Z, (2006) Cellular co-factors of HIV-1 integration. Trends Biochem Sci 31: 98-105.
14. Engelman A, Cherepanov P, (2008) The lentiviral integrase binding protein LEDGF/p75 and HIV-1 replication. PLoS Pathog 4: e1000046.
15. Poeschla EM, (2008) Integrase, LEDGF/p75 and HIV replication. Cell Mol Life Sci 65: 1403-1424.
16. Daniels T, Zhang J, Gutierrez I, Elliot ML, Yamada B, et al. (2005) Antinuclear autoantibodies in prostate cancer: immunity to LEDGF/p75, a survival protein highly expressed in prostate tumors and cleaved during apoptosis. Prostate 62: 14-26.
17. Daugaard M, Kirkegaard-Sørensen T, Ostenfeld MS, Aaboe M, Høyer-Hansen M, et al. (2007) Lens epithelium-derived growth factor is an Hsp70-2 regulated guardian of lysosomal stability in human cancer. Cancer Res 67: 2559-25567.
18. Singh DP, Fatma N, Kimura A, Chylack LT Jr, Shinohara T, (2001) LEDGF binds to heat shock and stress-related element to activate the expression of stress-related genes. Biochem Biophys Res Commun 283: 943-955.
19. Shin JH, Piao CS, Lim CM, Lee JK, (2008) LEDGF binding to stress response element increases alphaB-crystallin expression in astrocytes with oxidative stress. Neurosci Lett 435: 131-136.
20. Fatma N, Singh DP, Shinohara T, Chylack LT Jr, (2001) Transcriptional regulation of the antioxidant protein 2 gene, a thiol-specific antioxidant, by lens epithelium-derived growth factor to protect cells from oxidative stress. J Biol Chem 276: 48899-48907.
21. Basu A, Drame A, Munoz R, Gijsbers R, Debyser Z, et al. (2011) Pathway specific gene expression profiling reveals oxidative stress genes potentially regulated by transcription co-activator LEDGF/p75 in prostate cancer cancer cells. Prostate [July 27, Epub ahead of print].
22. Takeichi T, Sugiura K, Muro Y, Matsumoto K, Ogawa Y, et al. (2010) Overexpression of LEDGF/DFS70 induces IL-6 via p38 activation in HaCaT cells, similar to that seen in the psoriatic condition. J Invest Dermatol 130: 2760-2767.
23. Yokoyama A, Cleary ML, (2008) Menin critically links MLL proteins with LEDGF on cancer-associated target genes. Cancer Cell 14: 36-46.
24. Singh DP, Kimura A, Chylack LT Jr, Shinohara T, (2000) Lens epithelium-derived growth factor (LEDGF/p75) and p52 are derived from a single gene by alternative splicing. Gene 242: 265-273.
25. Brown-Bryan TA, Leoh LS, Ganapathy V, Pacheco FJ, Mediavilla-Varela M, et al. (2008) Alternative splicing and caspase-mediated cleavage generate antagonistic variants of the stress oncoprotein LEDGF/p75. Mol Cancer Res 6: 1293-1307.
26. Ahuja HG, Hong J, Aplan PD, Tcheurekdjian L, Forman SJ, et al. (2000) t(9;11)(p22;p15) in acute myeloid leukemia results in a fusion between NUP98 and the gene encoding transcriptional coactivators p52 and p75-lens epithelium-derived growth factor (LEDGF). Cancer Res 60: 6227-6229.
27. Morerio C, Acquila M, Rosanda C, Rapella A, Tassano E, et al. (2005) t(9;11)(p22;p15) with NUP98-LEDGF fusion gene in pediatric acute myeloid leukemia. Leuk Res 29: 467-470.
28. Grand FH, Koduru P, Cross NC, Allen SL, (2005) NUP98-LEDGF fusion and t(9;11) in transformed chronic myeloid leukemia. Leuk Res 29: 1469-1472.
29. Hussey DJ, Moore S, Nicola M, Dobrovic A, (2001) Fusion of the NUP98 gene with the LEDGF/p52 gene defines a recurrent acute myeloid leukemia translocation. BMC Genet 2: 20.
30. Huang TS, Myklebust LM, Kjarland E, Gjertsen BT, Pendino F, et al. (2007) LEDGF/p75 has increased expression in blasts from chemotherapy-resistant human acute myelogenic leukemia patients and protects leukemia cells from apoptosis in vitro. Mol Cancer 6: 31.
31. Mediavilla-Varela M, Pacheco FJ, Almaguel F, Sahakian E, Daniels TR, et al. (2009) Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75. Mol Cancer 8: 68.
32. Sapoznik S, Cohen B, Tzuman Y, Meir G, Ben-Dor S, et al. (2009) Gonadotropin-regulated lymphangiogenesis in ovarian cancer is mediated by LEDGF-induced expression of VEGF-C. Cancer Res 69: 9306-9314.
33. Basu A, Banerjee H, Rojas H, Martinez SR, Roy S, et al. (2011) Differential expression of peroxiredoxins in prostate cancer: consistent upregulation of PRDX3 and PRDX4. Prostate 71: 755-765.
34. Khan S, Jutzy JM, Aspe JR, McGregor DW, Neidigh JW, et al. (2011) Survivin is released from cancer cells via exosomes. Apoptosis 16: 1-12.
35. McCready J, Sims JD, Chan D, Jay DG, (2010) Secretion of extracellular hsp90alpha via exosomes increases cancer cell motility: a role for plasminogen activation. BMC Cancer 10: 294.
36. Merendino AM, Bucchieri F, Campanella C, Marcianò V, Ribbene A, et al. (2010) Hsp60 is actively secreted by human tumor cells. PLoS One 5: e9247.
37. Fatma N, Singh DP, Shinohara T, Chylack LT Jr, (2000) Heparin's roles in stabilizing, potentiating, and transporting LEDGF into the nucleus. Invest Ophthalmol Vis Sci 41: 2648-2657.
38. Ørntoft TF, Thykjaer T, Waldman FM, Wolf H, Celis JE, (2002) Genome-wide study of gene copy numbers, transcripts, and protein levels in pairs of non-invasive and invasive human transitional cell carcinomas. Mol Cell Proteomics 1: 37-45.
39. Kalinichenko SV, Kopantzev EP, Korobko EV, Palgova IV, Zavalishina LE, et al. (2008) Pdcd4 protein and mRNA level alterations do not correlate in human lung tumors. Lung Cancer 62: 173-180.
40. Cha MK, Suh KH, Kim IH, (2009) Overexpression of peroxiredoxin 1 and thioredoxin1 in human breast carcinoma. J Exp Clin Cancer Res 28: 93.
41. Chen G, Gharib TG, Huang CC, Taylor JM, Misek DE, et al. (2002) Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics 1: 304-313.
42. Shankavaram UT, Reinhold WC, Nishizuka S, Major S, Morita D, et al. (2007) Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study. Mol Cancer Ther 2007 6: 820-832.
43. Varambally S, Yu J, Laxman B, Rhodes DR, Mehra R, et al. (2005) Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell 8: 393-406.
44. Lo AK, To KF, Lo KW, Lung RW, Hui JW, et al. (2007) Modulation of LMP1 protein expression by EBV-encoded microRNAs. Proc Natl Acad Sci 104: 16164-16169.
45. Trujillo KA, Heaphy CM, Mai M, Vargas KM, Jones AC, et al. (2010) Markers of fibrosis and epithelial to mesenchymal transition demonstrate field cancerization in histologically normal tissue adjacent to breast tumors. Int J Cancer Nov 23. [In print].
46. Heaphy CM, Bisoffi M, Fordyce CA, Haaland CM, Hines WC, et al. (2006) Telomere DNA content and allelic imbalance demonstrate field cancerization in histologically normal tissue adjacent to breast tumors. Int J Cancer 119: 108-116.
47. Lou C, Du Z, Yang B, Gao Y, Wang Y, et al. (2009) Aberrant DNA methylation profile of hepatocellular carcinoma and surgically resected margin. Cancer Sci 100: 996-1004.
48. Roesch-Ely M, Leipold A, Nees M, Holzinger D, Dietz A, et al. (2010) Proteomic analysis of field cancerization in pharynx and oesophagus: a prospective pilot study. J Pathol 221: 462-470.
49. Nonn L, Ananthanarayanan V, Gann PH, (2009) Evidence for field cancerization of the prostate. Prostate 69: 1470-1479.
50. Haaland CM, Heaphy CM, Butler KS, Fischer EG, Griffith JK, et al. (2009) Differential gene expression in tumor adjacent histologically normal prostatic tissue indicates field cancerization. Int J Oncol 35: 537-546.